Vir Biotechnology Inc. logo

Vir Biotechnology Inc. (VIR)

Delisted
5 Aug 2026
NASDAQ (NGS) NASDAQ (NGS)
$
9. 11
-0.06
-0.6543%
$
1.5B Market Cap
- P/E Ratio
- Div Yield
1.41M Volume
-4.1 Eps
$ 9.17
Previous Close
Day Range
9 9.36
Year Range
4.16 11.66
Want to track VIR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Vir Biotechnology Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Alan Gilmore
Alan Gilmore Private Wealth Management Group, LLC
920 $4,637 $7,967.2 $3,330.2 71.82%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
600 $5,376 $5,376 - -
Winfried Buchbauer
Winfried Buchbauer Erste Asset Management GmbH
180,800 $2.13M $1.57M -$567,456 -26.6%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
36,256 $274,734.24 $313,976.96 $39,242.72 14.28%
Pascal Bechtold
Pascal Bechtold Raiffeisen Bank International AG
125,000 $1.12M $1.08M -$37,500 -3.35%
BCG
BIT Capital GmbH BIT Capital GmbH
80,000 $778,300 $815,200 $36,900 4.74%
CW
Chung Wu Chung Wu Investment Group LLC
3,410 $30,554 $29,530.6 -$1,023.4 -3.35%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
3,327 $25,101.04 $24,419.86 -$681.18 -2.71%